Anil Matai Archives - Express Pharma

Anil Matai reflects on 2024 as a pivotal year for India’s pharma sector

Upskilling and reskilling: Key to driving innovation in India’s pharma sector

Bhushan Akshikar appointed OPPI President

DCGI waives off local trials for drugs approved in well-regulated markets

Union Budget 2024-25 reflects a forward-looking and inclusive approach

OPPI urges government to boost R&D and innovation in pharma sector ahead of Union Budget

Navigating the seas of change: Leadership in the age of disruption

Anil Matai appointed Director-General of OPPI

Jashvik Capital appoints Anil Matai and Vijender Singh as Operating Partners